SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001437749-24-020589
Filing Date
2024-06-18
Accepted
2024-06-18 07:02:08
Documents
17
Period of Report
2024-06-17
Items
Item 7.01: Regulation FD Disclosure
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K clnn20240611_8k.htm   iXBRL 8-K 30940
2 EXHIBIT 99.1 ex_686661.htm EX-99.1 1105
3 EXHIBIT 99.2 ex_686683.htm EX-99.2 18083
8 clene01.jpg GRAPHIC 362651
  Complete submission text file 0001437749-24-020589.txt   706140

Data Files

Seq Description Document Type Size
4 XBRL TAXONOMY EXTENSION SCHEMA clnn-20240617.xsd EX-101.SCH 3943
5 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE clnn-20240617_def.xml EX-101.DEF 13521
6 XBRL TAXONOMY EXTENSION LABEL LINKBASE clnn-20240617_lab.xml EX-101.LAB 17826
7 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE clnn-20240617_pre.xml EX-101.PRE 13498
20 EXTRACTED XBRL INSTANCE DOCUMENT clnn20240611_8k_htm.xml XML 4957
Mailing Address 6550 SOUTH MILLROCK DRIVE, SUITE G50 SALT LAKE CITY UT 84121
Business Address 6550 SOUTH MILLROCK DRIVE, SUITE G50 SALT LAKE CITY UT 84121 801-676-9695
Clene Inc. (Filer) CIK: 0001822791 (see all company filings)

IRS No.: 852828339 | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-39834 | Film No.: 241050159
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)